Published in Arch Immunol Ther Exp (Warsz) on January 01, 1979
The use of laboratory tests in the diagnosis of SLE. J Clin Pathol (2000) 1.92
Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine (2000) 2.25
Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett (2001) 2.15
Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett (1987) 1.62
HLA-B27-associated spondylarthritis in chronic brucellosis. Lancet (1978) 1.51
[Interleukin-6: friend or enemy? Latest findings on the clinical aspects of IL-6]. Orv Hetil (1994) 1.49
[Fatal myocardial lesion in systemic lupus erythematosus]. Orv Hetil (1993) 1.39
Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res (2009) 1.34
Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol (2001) 1.29
Interleukin 6 levels in synovial fluids of patients with different arthritides: correlation with local IgM rheumatoid factor and systemic acute phase protein production. J Rheumatol (1992) 1.25
Histamine: an early messenger in inflammatory and immune reactions. Immunol Today (1992) 1.20
Electrostatic complementarity within the substrate-binding pocket of trypsin. Proc Natl Acad Sci U S A (1988) 1.14
Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin-dependent diabetes mellitus. Pediatr Res (1999) 1.12
Modification of acidic residues normalizes sodium dodecyl sulfate-polyacrylamide gel electrophoresis of caldesmon and other proteins that migrate anomalously. Arch Biochem Biophys (1992) 1.10
Constitutive and IL 1-regulated murine complement gene expression is strain and tissue specific. J Immunol (1987) 1.09
IgE and IgE-rheumatoid factors in circulating immune complexes in rheumatoid arthritis. Ann Rheum Dis (1982) 1.09
Increased interleukin-6 levels, interleukin-6 receptor and gp130 expression in peripheral lymphocytes of patients with inflammatory bowel disease. Scand J Gastroenterol Suppl (1998) 1.09
Radioimmune double PEG precipitation technique for detecting complexed IgE. J Immunol Methods (1979) 1.06
Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma. Cell Biol Int (2000) 1.06
Mouse plasmacytoma: an experimental model of human multiple myeloma. Haematologica (2001) 1.06
CD4(+)CD8(+)TCR(low) thymocytes express low levels of glucocorticoid receptors while being sensitive to glucocorticoid-induced apoptosis. Eur J Immunol (2001) 1.00
Production and flow cytometric application of a monoclonal anti-glucocorticoid receptor antibody. J Immunol Methods (1998) 0.98
IgE class immune complexes in Felty's syndrome: characterisation of antibody activities in isolated complexes. Ann Rheum Dis (1984) 0.97
Biological and clinical significance of the JAK-STAT pathway; lessons from knockout mice. Inflamm Res (2001) 0.97
Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies. Int Arch Allergy Appl Immunol (1981) 0.96
The fifth component of complement (C5) in the mouse. Analysis of the molecular basis for deficiency. J Exp Med (1987) 0.96
Serological abnormalities in juvenile chronic arthritis: a review of 46 cases. Ann Rheum Dis (1980) 0.93
Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases. Rheumatology (Oxford) (2003) 0.93
Meta-analysis of adrenocortical tumour genomics data: novel pathogenic pathways revealed. Oncogene (2010) 0.92
N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine increases the permeability of primary mouse cerebral endothelial cell monolayers. Inflamm Res (2003) 0.92
Measurement of intracellular interferon-gamma and interleukin-4 in whole blood T lymphocytes from patients with systemic lupus erythematosus. Immunol Lett (2000) 0.92
Evaluation of different methods for detecting circulating immune complexes. An inter-laboratory study. J Immunol Methods (1980) 0.92
Increased interferon-gamma- and interleukin-4-synthesizing subsets of circulating T lymphocytes in pregnant asthmatics. Clin Exp Allergy (2005) 0.91
The role of T-lymphocytes and cytokines in rheumatoid arthritis. Scand J Rheumatol (1996) 0.91
Targeted deletion of histidine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss. Proc Natl Acad Sci U S A (2003) 0.90
Disulfide cross-linking of caldesmon to actin. J Biol Chem (1991) 0.89
Asthma from a pharmacogenomic point of view. Br J Pharmacol (2008) 0.89
Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production. Immunol Lett (2000) 0.89
In vivo pulmonary toxicity of cellulose in rats. J Appl Toxicol (1997) 0.88
Inhibition of antigen-specific T cell trafficking into the central nervous system via blocking PECAM1/CD31 molecule. J Neuropathol Exp Neurol (2001) 0.88
DNA polymorphism of MHC III genes in inbred and wild mouse strains. Immunogenetics (1987) 0.87
Scallop striated and smooth muscle myosin heavy-chain isoforms are produced by alternative RNA splicing from a single gene. Proc Natl Acad Sci U S A (1994) 0.87
Human beta 2-microglobulin is a substrate of tissue transglutaminase: polymerization in solution and on the cell surface. J Cell Biol (1981) 0.87
Subsets in psoriatic arthritis formed by cluster analysis. Clin Rheumatol (2001) 0.87
Interrelationship between the immunological and steroid hormone parameters in rheumatoid arthritis. Exp Clin Endocrinol (1986) 0.86
Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy. Pharmacogenomics J (2008) 0.86
Role of cellulose in wood dust-induced fibrosing alveo-bronchiolitis in rat. J Appl Toxicol (1995) 0.86
T lymphocytes are targets for platelet- and trophoblast-derived microvesicles during pregnancy. Placenta (2008) 0.85
Aetiology of keratoconjunctivitis in epidemic and non-epidemic periods. Acta Microbiol Acad Sci Hung (1965) 0.85
Antibody and immunoglobulin levels in aged humans. Arch Gerontol Geriatr (1984) 0.84
Beta2-microglobulin-containing IgG complexes in sera and synovial fluids of rheumatoid arthritis and systemic lupus erythematosus patients. Scand J Immunol (1981) 0.84
Cholinergic signals to and from the immune system. Immunol Lett (1995) 0.83
Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012-1704) of the TSH receptor gene in Graves' disease. Eur J Immunogenet (2000) 0.83
Essential and regulatory light chains of Placopecten striated and catch muscle myosins. J Muscle Res Cell Motil (1996) 0.83
Histamine influences the expression of the interleukin-6 receptor on human lymphoid, monocytoid and hepatoma cell lines. Agents Actions (1991) 0.83
Safety aspects of intravenous immunoglobulins. Immunol Invest (1988) 0.83
Modulation of glucocorticosteroid binding in human lymphoid, monocytoid and hepatoma cell lines by inflammatory cytokines interleukin (IL)-1 beta, IL-6 and tumour necrosis factor (TNF)-alpha. Scand J Immunol (1993) 0.83
Histidine decarboxylase expression in human melanoma. J Invest Dermatol (2000) 0.83
Cytokine regulation of the acute-phase protein levels in multiple myeloma. Eur J Clin Invest (1998) 0.82
Some aspects of interindividual variations in the metabolism of xenobiotics. Inflamm Res (2003) 0.82
Transport of mast cells by the blood circulation. Experientia (1969) 0.82
Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation. Immunol Lett (2001) 0.82
Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, is regulated by melanoma-derived histamine. Semin Cancer Biol (2000) 0.82
Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes. Cytokine (1998) 0.81
Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis. Med Sci Monit (2001) 0.81
Microencapsulation technology by nature: Cell derived extracellular vesicles with therapeutic potential. Eur J Microbiol Immunol (Bp) (2013) 0.81
H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells. Semin Cancer Biol (2000) 0.81
Natural antibody production in human tonsils. Experientia (1972) 0.81
Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotides. J Invest Dermatol (2001) 0.81
Autoantibodies specific to beta-2-microglobulin inhibit the Fc receptor-dependent phagocytosis of human monocytes. Immunol Lett (1981) 0.81
Evaluation of different methods for detecting circulating immune complexes. Studies in patients with lung cancer. J Immunol Methods (1981) 0.81
Differences between human lymphocyte subpopulations with respect to the uptake and incorporation of [3H]uridine and ribonucleoside triphosphate pools. Biochem Med (1978) 0.80
Inhibition of human primary melanoma cell proliferation by histamine is enhanced by interleukin-6. Eur J Clin Invest (2002) 0.80
Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation. Trends Immunol (2001) 0.80
Prevalence of anti-beta-2 microglobulin autoantibodies in sera of rheumatoid arthritis patients with extra-articular manifestations. Ann Rheum Dis (1981) 0.80
Complexed rheumatoid factor measurements in sera, synovial fluids and in immune complex fractions. Experientia (1979) 0.80
Histamine as a potential autocrine regulator of melanoma. Inflamm Res (2001) 0.80
[Association between cumulative familial incidence of type I diabetes and rheumatoid arthritis]. Orv Hetil (1985) 0.80
Effect of histamine on the gene expression and biosynthesis of complement components C2, factor B and C3 in mouse peritoneal macrophages. Immunology (1987) 0.80
Interleukin-6-induced production of type II acute phase proteins and expression of junB gene are downregulated by human recombinant growth hormone in vitro. Cell Biol Int (2000) 0.80